Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2015

View Archived Issues

Researchers identify highly potent dengue-neutralizing MAb

ID Pharma enters new agreement with National Institute of Infectious Diseases of Japan

Atlas Genetics enters into diagnostic collaboration based on io system

Grant supports InMed's development of nanoparticle-based delivery system for glaucoma

Sanofi and Innate Pharma to collaborate on antibody-drug conjugates for cancer

SELLAS unites with TrojanTec on TR-1 cancer technology

Cystic Fibrosis Foundation Therapeutics and Genzyme expand collaboration

NeuroVive partners with Isomerase Therapeutics on NVP-014 for stroke

AnaptysBio initiates IND-enabling studies of anti-IL-36R MAb ANB-019

Novel mutation in the PEX3 gene may cause lethal ZSS

New company Oncurious to develop TB-403 for brain tumors

HIF-2alpha antagonist PT-2385 for clear cell renal carcinoma

ProMetic to raise USD 50 million in share deal

HER2-targeting ADC shows promise as a stable targeted therapeutic for multiple cancers

Cepheid's point-of-care HCV and HIV tests receive European approval

Novel immunotherapy combination improves outcome in no-sq NSCLC patients

Shenzhen Qianhai Taxus invests in Angionetics

WHO grants INNs for two Hanmi drugs

Phase III study of Opdivo in NSCLC stopped early after meeting primary endpoint

FDA awards orphan drug status to Samcyprone for malignant melanoma stage IIB to IV

Reolysin receives FDA orphan drug designation for malignant glioma

Ventria Bioscience develops fusion protein as vaccine for Lyme disease

U.S. HHS patent covers anti-JC virus ASOs

Jiva Pharma reports metformin salts

Peking University reports 14-3-3E inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...